SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010788
Filing Date
2023-06-05
Accepted
2023-06-05 07:00:23
Documents
16
Period of Report
2023-06-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230603x8k.htm   iXBRL 8-K 46670
2 EX-99.1 elev-20230603xex99d1.htm EX-99.1 29867
3 EX-99.2 elev-20230603xex99d2.htm EX-99.2 5864
4 GRAPHIC elev-20230603xex99d2g001.jpg GRAPHIC 420292
  Complete submission text file 0001558370-23-010788.txt   886594

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20230603.xsd EX-101.SCH 3265
6 EX-101.LAB elev-20230603_lab.xml EX-101.LAB 632
7 EX-101.PRE elev-20230603_pre.xml EX-101.PRE 10889
10 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230603x8k_htm.xml XML 4996
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 23991200
SIC: 2836 Biological Products, (No Diagnostic Substances)